D3-Pharmacy Aps: Financial statements 2022
CVR: 71087611
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
D3-Pharmacy Aps (CVR 71087611) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,365 and a net result of DKK -17,788 compared with DKK -7,169 the year before. Equity in the 2022 report amounted to DKK 548,913. The solvency ratio was 52.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -10,365
- Profit/Loss
- DKK -17,788
- Equity
- DKK 548,913
- Total Assets
- DKK 1,039,740
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -10 t. | -18 t. | 549 t. | 1 |
| 2021 | - | -3 t. | -7 t. | 567 t. | 1 |
| 2020 | - | -8 t. | -14 t. | 574 t. | 1 |
| 2019 | - | -8 t. | -14 t. | 588 t. | 1 |
| 2018 | - | -7 t. | -11 t. | 600 t. | 0 |
Official annual report
Keep an eye on D3-Pharmacy Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
D3-Pharmacy Aps has published its annual report for 2021. Gross profit came to DKK -2,662, and the net result was DKK -7,169.
About D3-Pharmacy Aps
D3-Pharmacy Aps is a Danish company of the type Anpartsselskab based in Svenstrup J, founded in 1982. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Finn Jørgen Jensen. The company is owned by Finn Jørgen Jensen. According to the 2023 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,710 and a net result of DKK -4,037 compared with DKK -13,135 the year before. Equity in the 2025 report amounted to DKK 526,147.